MFS Value Fund
MFS SERIES TRUST I · Series S000000769 · 9 share classes
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2025 Q4
The funds investment objective is to seek capital appreciation.
No strategy summary for this fund. We write them from the strategy narrative a fund files, for funds holding $250m or more in net assets — a fund under that line, or one whose filing carries no narrative, has none.
| Share class | Gross | Net |
|---|---|---|
| MEIAX | 0.80% | 0.79% |
| MEIJX | 0.55% | 0.54% |
| MFEBX | 1.55% | 1.54% |
| MEICX | 1.55% | 1.54% |
| MEIIX | 0.55% | 0.54% |
| MEIGX | 1.55% | 1.54% |
| MVRRX | 1.05% | 1.04% |
| MEIHX | 0.80% | 0.79% |
| MEIKX | 0.45% | 0.44% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 10.00% · as of 2025 Q4
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.82% |
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +18.05% | +43.37% | +48.81% | 9.53% | -7.49% | |
| +18.32% | +44.42% | +50.60% | 9.50% | -7.44% | |
| +17.16% | +40.19% | +43.34% | 9.52% | -7.68% | |
| +17.19% | +40.16% | +43.30% | 9.53% | -7.68% | |
| +18.36% | +44.47% | +50.70% | 9.53% | -7.44% | |
| +17.16% | +40.19% | +43.30% | 9.52% | -7.65% | |
| +17.75% | +42.30% | +46.91% | 9.52% | -7.55% | |
| +18.08% | +43.40% | +48.85% | 9.53% | -7.49% | |
| +18.51% | +44.95% | +51.53% | 9.52% | -7.42% |
These classes hold the same portfolio, so the 8.23pp spread over 5 years is the cost difference between them — roughly 1.65pp a year — not a difference in what they own.
May 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| JPM | JPMorgan Chase & CoJPM | 4.28% | $299.31 | $2.19B | 7.3M |
| CI | The Cigna GroupCI | 2.80% | $277.40 | $1.43B | 5.2M |
| JNJ | Johnson & JohnsonJNJ | 2.75% | $225.33 | $1.41B | 6.2M |
| ADI | Analog Devices IncADI | 2.71% | $413.85 | $1.39B | 3.3M |
| MS | Morgan StanleyMS | 2.68% | $208.00 | $1.37B | 6.6M |
| RTX | RTX CorpRTX | 2.50% | $179.66 | $1.28B | 7.1M |
| KLAC | KLA CorpKLAC | 2.47% | $1,921.71 | $1.26B | 656.8K |
| PGR | The Progressive CorpPGR | 2.45% | $190.40 | $1.25B | 6.6M |
| BA | The Boeing CoBA | 2.42% | $231.15 | $1.24B | 5.4M |
| XOM | Exxon Mobil CorpXOM | 2.33% | $145.26 | $1.19B | 8.2M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
Top 10 positions are 27.40% of net assets, top 25 56.52%, across 71 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free